Visit www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including Johnson & Johnson's consideration of a generic drug division and Medicare's off-label coverage of cancer drugs. To sign up for a free trial of 1"The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
The former CDER director said she tells sponsors not to conduct an FDA-recommended study design or randomized trial if it will not work.
Artificial intelligence tools used for clinical research should be developed with input from patients and focus on their needs and abilities, FDA experts said.
The UK government is making it easier for millions of people to participate in clinical trials and is boosting transparency around how studies are delivered across the National Health Service.
